ARTICLE | Company News
onepharm, Wuhan Huana Biological Engineering Co. Ltd. deal
March 23, 2009 7:00 AM UTC
onepharm acquired Wuhan's patent covering the use of OPM-3023 to treat inflammatory bowel disease (IBD). Wuhan has completed preclinical testing of the small molecule against an undisclosed target fo...